Skip to main content
. 2016 Nov 1;7:409. doi: 10.3389/fphar.2016.00409

FIGURE 1.

FIGURE 1

Cellular pathways currently being targeted in the treatment of endometrial cancer (EC) and the potential actionable genes in EC identified via Next Generation Sequencing (NGS). Red star depicted genes with clinically cancer-relevant drug interactions as defined by DGIdb (Wagner et al., 2016). (A) PI(3)K, MAPK, p53 and apoptosis pathway involving PIK3CA, PTEN, PPP2R1A, KRAS, P53, and BCL2, (B) cell cycle pathway involving FBXW7 and CCNE1 as well as (C) DNA replication pathway in eukaryote which involves POLE (DNA polymerase 𝜀). Figures were adapted from Kanehisa et al. (2016) and Seshagiri (2013). Adapted by permission from Macmillan Publishers Ltd: [NATURE GENETICS] (Seshagiri), copyright (2013).